Detalhe da pesquisa
1.
METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis.
EMBO Rep
; 24(3): e55762, 2023 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36597993
2.
circMYBL2, a circRNA from MYBL2, regulates FLT3 translation by recruiting PTBP1 to promote FLT3-ITD AML progression.
Blood
; 134(18): 1533-1546, 2019 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31387917
3.
The snoRNA-like lncRNA LNC-SNO49AB drives leukemia by activating the RNA-editing enzyme ADAR1.
Cell Discov
; 8(1): 117, 2022 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36316318
4.
Chromatin-associated orphan snoRNA regulates DNA damage-mediated differentiation via a non-canonical complex.
Cell Rep
; 38(13): 110421, 2022 03 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35354054
5.
N6-methyladenosine methyltransferases: functions, regulation, and clinical potential.
J Hematol Oncol
; 14(1): 117, 2021 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34315512
6.
Cis-acting lnc-eRNA SEELA directly binds histone H4 to promote histone recognition and leukemia progression.
Genome Biol
; 21(1): 269, 2020 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33143730
7.
Nuclear export of chimeric mRNAs depends on an lncRNA-triggered autoregulatory loop in blood malignancies.
Cell Death Dis
; 11(7): 566, 2020 07 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32703936
8.
The lncRNA LAMP5-AS1 drives leukemia cell stemness by directly modulating DOT1L methyltransferase activity in MLL leukemia.
J Hematol Oncol
; 13(1): 78, 2020 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32552847
9.
Activation of the Lysosome-Associated Membrane Protein LAMP5 by DOT1L Serves as a Bodyguard for MLL Fusion Oncoproteins to Evade Degradation in Leukemia.
Clin Cancer Res
; 25(9): 2795-2808, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30651276
10.
circRNA circAF4 functions as an oncogene to regulate MLL-AF4 fusion protein expression and inhibit MLL leukemia progression.
J Hematol Oncol
; 12(1): 103, 2019 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31623653
11.
A CRISPR/CAS9-based strategy targets the personalized chimeric neosequence in fusion-driven cancer genome for precision medicine.
Clin Transl Med
; 11(3): e355, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33783997
12.
Correction to: The lncRNA LAMP5-AS1 drives leukemia cell stemness by directly modulating DOT1L methyltransferase activity in MLL leukemia.
J Hematol Oncol
; 14(1): 42, 2021 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33706768